Atlas Trials

Clinical Research for Azacitidine Combined With Low-dose Dasatinib in Maintenance Therapy of Acute Myeloid Leukemia

Clinical trial NCT05042531 · UNKNOWN

Trial details

NCT number
NCT05042531
Sponsor
LanZhou University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Acute Myeloid Leukemia
Start date
2021-11-13
Primary completion
2023-09-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.